Enlimomab, CAS 142864-19-5

Product Description: Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research[1] [2] .

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]J Vuorte, et al. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol. 1999 Feb 15;162(4):2353-7. /[2][2]Gregory J del Zoppo. Acute anti-inflammatory approaches to ischemic stroke. Ann N Y Acad Sci. 2010 Oct;1207:143-8.

CAS Number: 142864-19-5

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology; Neurological Disease

Solubility: 10 mM in DMSO

Target: Integrin

• Artikelnummer: MEXHY-P99336-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99336-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK